IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
High-grade gliomas (HGG) are devastating diseases in children and adults. In the pediatric population, diffuse midline gliomas (DMG) harboring H3K27 alterations are the most aggressive primary malignant brain tumors. With no effective therapies available, children typically succumb to disease within...
Saved in:
Main Authors: | Julian S. Rechberger (Author), Kendra A. Porath (Author), Liang Zhang (Author), Cody L. Nesvick (Author), Randy S. Schrecengost (Author), Jann N. Sarkaria (Author), David J. Daniels (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
by: Maxim A.X. Tollenaere, et al.
Published: (2023) -
Investigation on Probable Association Between IL-13, IL-13RA1, and IL-13RA2 Genes Polymorphism and Pulmonary Tuberculosis
by: Li HM, et al.
Published: (2022) -
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
by: Ruijia Liang, et al.
Published: (2022) -
IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients
by: Maryam Karamikheirabad, et al.
Published: (2024) -
Selective IL-13 inhibitors for the treatment of atopic dermatitis
by: Francisca Gonçalves, et al.
Published: (2021)